Prevention of Metabolic Syndrome in Serious Mental Illness

Rohan Ganguli, Martin Strassnig

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations


The interaction of lifestyle, socioeconomic status, genetic factors, and treatment with antipsychotic medications likely accounts for the high risk of metabolic syndrome, diabetes, heart disease, and premature mortality in people with serious mental illness. Given the high risk of developing diabetes and cardiovascular disease in persons with serious mental illness, psychiatrists who treat these individuals need to ensure they are familiar with these risks, monitor metabolic parameters in their patients, and educate their patients (and caregivers) about the risks and how to prevent them.

Original languageEnglish (US)
Pages (from-to)109-125
Number of pages17
JournalPsychiatric Clinics of North America
Issue number1
StatePublished - Mar 2011


  • Antipsychotic medication
  • Lifestyle management
  • Mental illness
  • Metabolic syndrome

ASJC Scopus subject areas

  • Psychiatry and Mental health


Dive into the research topics of 'Prevention of Metabolic Syndrome in Serious Mental Illness'. Together they form a unique fingerprint.

Cite this